Project description
Preparing to respond to future pandemics
The effects of the COVID-19 pandemic signal the need to build better preparedness for future threats. The EU-funded ORCHESTRA project provides an innovative method to study the pandemic and deliver recommendations for future health crises. Specifically, it will establish a new EU-wide cohort based on existing and new large-scale population cohorts in the EU and non-European countries. ORCHESTRA will perform data analysis through a federated learning technique enhanced by pioneering modelling capabilities to integrate epidemiological, clinical, microbiological and genotypic aspects of population-based cohorts with environmental and socioeconomic elements. The project includes infected and non-infected individuals of all ages and conditions, focusing on at-risk populations of vulnerable individuals and healthcare workers.
Objective
The ORCHESTRA project provides an innovative approach to learn from the SARS-CoV-2 health crisis and derive recommendations for increasing preparedness for future outbreaks. The main outcome of the project is the creation of a new pan-European cohort built on existing and new large-scale population cohorts in European and non-European countries. Data analysis through a federated learning technique supported by advanced modelling capabilities will allow the integration of epidemiological, clinical, microbiological and genotypic aspects of population-based cohorts with environment and socio-economic features. The ORCHESTRA cohort will include SARS-CoV-2 infected and non-infected individuals of all ages and conditions and thereby enabling a retrospective evaluation of risk factors for the disease acquisition and progression of the disease and prospective follow-up aimed at exploring long term consequences and analysis of vaccination response. To better address these research questions, the ORCHESTRA-cohort will include adequately sampled representatives of general populations, COVID-19 patients and special ‘at risk’ populations of fragile individuals and health-care workers. The project aims also to evaluate how the acquisition of SARS-CoV-2 variants impacts on the severity of disease. ORCHESTRA will specifically assess the immunity function status in vaccinated and not vaccinated health care workers, including assessment in-between the first and the second dosages of any available vaccine and explore differences in level and durability of antibody immune responses and frequency of breakthrough infections (symptomatic and asymptomatic) in fragile population (e.g oncological, transplanted, hematological, HIV-infected and suffering from Parkison disease). The understanding of the evoked immune response by population, variants and type of vaccine are key to better understand how vaccines againstSARS-CoV-2 variants can prevent transmission and severe SARS-CoV-2 infections, why certain variants may be able to escape vaccines, and whether refresher boosters at regular intervals could change any of these outcomes. The participation of non-European and Low-Medium Income Countries and a Global COVID-19 Guidance group of major stakeholders and investigators from successful clinical trials addressing therapeutic approaches to COVID-19, ensures inclusion of all expertise needed and translation of recommendations to different social and economic settings. The project will significantly impact on the responsiveness to SARS-CoV-2 and can be used as a model for responsiveness for new public health threats.
Fields of science
- medical and health scienceshealth sciencespublic healthepidemiologyepidemics prevention
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health sciencesbasic medicineimmunology
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
Keywords
Programme(s)
Call for proposal
H2020-SC1-PHE-CORONAVIRUS-2020-2
See other projects for this callSub call
H2020-SC1-PHE-CORONAVIRUS-2020-2-RTD
Funding Scheme
RIA - Research and Innovation actionCoordinator
37129 Verona
Italy
See on map
Participants (33)
Legal entity established in a non-associated third country that is not eligible for funding under Article 10 of the Regulation (EU) No 1290/2013 laying down the rules for participation and dissemination in Horizon 2020.
121001 Faridabad
See on map
Legal entity established in a non-associated third country that is not eligible for funding under Article 10 of the Regulation (EU) No 1290/2013 laying down the rules for participation and dissemination in Horizon 2020.
04021001 Sao Paulo
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
37126 Verona
See on map
Legal entity established in a non-associated third country that is not eligible for funding under Article 10 of the Regulation (EU) No 1290/2013 laying down the rules for participation and dissemination in Horizon 2020.
560034 Bangalore
See on map
40126 Bologna
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
40124 Bologna
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
40138 Bologna
See on map
75654 Paris
See on map
41071 Sevilla
See on map
40033 Casalecchio Di Reno Bo
See on map
1445 Strassen
See on map
75012 Paris
See on map
40127 Bologna
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
42100 Reggio Emilia
See on map
08036 Barcelona
See on map
80539 MUNCHEN
See on map
2000 Antwerpen
See on map
85764 Neuherberg
See on map
50937 Koeln
See on map
35127 Padova
See on map
70174 Stuttgart
See on map
118 Lambaréné
See on map
975 56 BANSKA BYSTRICA
See on map
10117 Berlin
See on map
9713 GZ Groningen
See on map
34097 Montpellier
See on map
33003 OVIEDO
See on map
1053 Buenos Aires
See on map
050463 Bucuresti
See on map
69120 Heidelberg
See on map
30123 Venezia
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
35131 Padova
See on map
Brazzaville
See on map